Skip to content
Explore the latest in technology, innovation, and digital t…

Giving Stem Cells During Pregnancy to Babies with Spina Bifida Improves Quality of Life, Research Shows

A groundbreaking research effort has discovered that administering stem cells to fetuses diagnosed with spina bifida during corrective surgery could constitute a "important advancement" in managing prenatal disorders.

Research Framework and Assurance

The research conducted in the United States involved six developing infants with a severe neural tube defect. Doctors administered mother's placental stem cells to the surface of the developing neural column while the defect was being closed.

Importantly, the regenerative treatment was found to be safe. The study team reported that the treatment did not lead to cancerous growths, interfere with wound healing, or prevent the reversal of co-occurring hindbrain herniation.

Promising Outcomes

Imaging conducted after delivery confirmed a full resolution of brainstem displacement in each of the babies. This favorable anatomical change is closely linked to improved motor skills and quality of life.

"Should it enable more children capable of walking who previously could not, it may emerge as their standard of care," noted the study director. "These findings are extremely promising and open the door to lots of potential new treatments."

Long-Term Prospects and Optimism

Commentators reviewing the findings have suggested that additional validation of these noted improvements could signal a "different age" in prenatal intervention. The potential to improve nerve function impairment seen in utero is viewed as a transformative goal.

Particularly welcome would be advancements for continence and digestive health, which are typical difficulties for individuals living with this defect.

Future Directions

Despite this being a first-in-human effort was small in scale, its established security and encouraging indicators create a solid basis for broader investigative efforts. The addition of cellular treatment with current in-utero repair procedures offers substantial hope for improving the prognosis for babies yet to be born with myelomeningocele.

By

Patrick Wilson

A tech futurist and digital strategist passionate about exploring how emerging technologies impact society and business.

RapidWorld

Type to search articles.